Consistent with these findings, our in vitro experiments demonstrated that inhibition of Mstn markedly attenuated tumor cell–induced osteoclastogenesis and bone resorption, effects that were mediated through SMAD2 signaling. This evidence concerns the gene MSTN and neoplasm.